Corporate VC · Israel

Dexcel Pharma

Active

Who they back

DeepTechHealthtechBiotechSeedSeries A

Business models

biotech_therapeutics

Customer segments

Patients, Healthcare providers, Pharmaceutical partners

Geography

US, Europe, UK, Israel

Recent investments

  • Roivant Sciences
  • Clexio Biosciences
  • Dexoligo Therapeutics

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Dexcel Pharma writes strategic capital from an operating company. The thesis is usually narrower than a financial fund, but the value-add (customer intros, distribution, technical resources) is often what closes the round when the cap table is competitive. VC Boom tracks Dexcel Pharma alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Israel
Portfolio last checked
Oct 6, 2026
Website
dexcel.com ↗

Other firms investing in DeepTech

See all investors

Is Dexcel Pharma the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Dexcel Pharma is one of them, and we'll tell you exactly where they sit in your top 100.